Latest Articles
More than two thirds of women in London say contraception delayed a life-changing diagnosis - London TV
More than two thirds of women in London say contraception delayed a life-changing diagnosis London TV
Published: Dec. 6, 2025, 2:36 a.m.
The Impact of Hormone Replacement Therapy on Endometrial Pathology: A Retrospective Observational Study - Cureus
The Impact of Hormone Replacement Therapy on Endometrial Pathology: A Retrospective Observational Study Cureus
Published: Dec. 4, 2025, 4:59 a.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - BioSpace
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia BioSpace
Published: Dec. 3, 2025, 2:11 p.m.
Study challenges menstrual taboo to promote more inclusive workplaces - FemTech World
Study challenges menstrual taboo to promote more inclusive workplaces FemTech World
Published: Dec. 3, 2025, 2:10 p.m.
Kilkenny events in support of Palestine to take place this weekend - Kilkenny People
Kilkenny events in support of Palestine to take place this weekend Kilkenny People
Published: Dec. 1, 2025, 12:32 p.m.
New research challenges menstrual taboo to promote more inclusive workplaces - Phys.org
New research challenges menstrual taboo to promote more inclusive workplaces Phys.org
Published: Nov. 30, 2025, 7:40 p.m.
She was described as a 'culinary visionary' - facebook.com
She was described as a 'culinary visionary' facebook.com
Published: Nov. 23, 2025, 10:45 p.m.
Genmab Prunes Another ADC From $1.8B ProfoundBio Acquisition - BioSpace
Genmab Prunes Another ADC From $1.8B ProfoundBio Acquisition BioSpace
Published: Nov. 18, 2025, 1:40 p.m.
Thousands face delayed diagnosis as common pill may mask symptoms - Surrey Live
Thousands face delayed diagnosis as common pill may mask symptoms Surrey Live
Published: Nov. 17, 2025, 2:31 p.m.
Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) - BioSpace
Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) BioSpace
Published: Nov. 14, 2025, 11:59 a.m.
Link copied to clipboard!